Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

945 results about "In vitro experiment" patented technology

Definition: In Vitro. The term in vitro, in contrast to in vivo, refers to a medical study or experiment which is done in the laboratory within the confines of a test tube or laboratory dish.

Engineered three-dimensional connective tissue constructs and methods of making the same

Disclosed are engineered, living, three-dimensional connective tissue constructs comprising connective tissue cells. In some embodiments, the connective tissue cells are derived from multi-potent cells such as mesenchymal stem / stromal cells. In some embodiments, the cells are cohered to one another. In some embodiments, the multi-potent cells have been exposed to one or more differentiation signals to provide a living, three-dimensional connective tissue construct. In some embodiments, the constructs are substantially free of pre-formed scaffold at the time of use. Also disclosed are implants for engraftment, arrays of connective tissue constructs for in vitro experimentation, as well as methods of making the same.
Owner:ORGANOVO

Preparation method and application of tumor-targeted nanometer drug delivery system for cooperative chemotherapy and photodynamic therapy

The invention discloses a tumor-targeted nanometer drug delivery system for cooperative chemotherapy and photodynamic therapy and a preparation method thereof. The drug delivery system is prepared from carboxymethyl chitosan, folate, a photosensitizer chlorine e6 and adriamycin, wherein the chlorine e6 and the folate are coupled to a carboxymethyl chitosan chain segment through an amido bond, and are loaded to polymer nanoparticles of the adriamycin through an ion exchange method. The nanometer material prepared by the method is high in yield, regular in shape and even in distribution. In-vivo and in-vitro experiments prove that the tumor targeting property of the nanometer preparation can be significantly improved by folate receptor mediation; enrichment on the tumor part is achieved and drug release is controlled. The photosensitizer is capable of effectively reversing the chemotherapy drug resistance and significantly inhibiting the growth of tumors after being irradiated by near-infrared light. Therefore, the related nanometer drug delivery system has good application prospect in the aspect of breast cancer treatment.
Owner:SHENYANG UNIV

Biogastrone acid-polyethyleneglycol /chitosan liver target composite drug administration system and preparation thereof

InactiveCN101254308AThe method is novel and simpleMild conditions for pelletingOrganic active ingredientsPharmaceutical non-active ingredientsCancer cellPolyethylene glycol
The invention relates to a novel liver target drug carrier-glycyrrhetinic acid-polyethylene glycol / chitosan or chitosan derivative liver target compound drug delivery system. During the preparation of the nano-drug delivery system, the liver target small-molecule glycyrrhetinic acid is firstly used for modifying amino polyethylene glycol by the different sites, then a water soluble big-molecule liver target compound is prepared and is mixed with a solution containing chitosan or chitosan derivative by a certain proportion, an ion cross-linking agent is added under the stirring condition, and a target group is introduced at the same time of the spontaneous formation of nanoparticles by physical winding and electrostatic interaction. The method of introducing the target group of the invention is novel, the formation of spheres is simple, the conditions are moderate, and the content of the target group is high (the weight percentage of glycyrrhetinic acid is 5 to 30 percent). The drug delivery system has strong killing capacity to the cancer cells, the in vitro experiments show that the drug delivery system has very strong binding capacity with the liver cells, and the high content of the target group can improve the liver target capacity of the drug delivery system, realize the target positioning of the liver and open a new way for the treatment of liver cancer.
Owner:NANKAI UNIV

A kind of preparation method and application of multivesicular liposome

The invention relates to a multi-vesicular liposome, a blank multi-vesicular liposome and a preparation method and application thereof. The multi-vesicular liposome contains the following components in part by weight: 1 part of liposome, 0.01 to 20 parts of auxiliary emulsifier, 1 to 50 parts of osmotic pressure regulator and medicinal active ingredients; the medicament-to-lipid ratio of the multi-vesicular liposome is 1:(0.1-1):200; the lipid contains of a specific amount of neutral phospholipid, cholesterol and triglyceride; and the auxiliary emulsifier is selected from dextran, polyvinyl pyrrolidone, hydroxyethyl starch, gelatin, albumin, arginine and hydroxymethyl starch. The blank multi-vesicular liposome contains the following components in part by weight: 1 part of lipid, 0.01 to 20 parts of auxiliary emulsifier, 1 to 50 parts of osmotic pressure regulator and 0.1 to 50 parts of ion gradient regulator; the osmotic pressure of the in vivo water phase of the multi-vesicular liposome is equal to the osmotic pressure of human plasma; and the auxiliary emulsifier is as previously mentioned. The multi-vesicular liposome has high entrapment rate, and can achieve good sustained-release effect on in vivo and in vitro experiments.
Owner:SHANGHAI MODERN PHARMA ENG INVESTIGATION CENT

Detecting micro-needle with strengthened Raman and fluorescence signal and preparation method thereof

The invention discloses a detecting micro-needle with a strengthened Raman and a fluorescence signal and a preparation method of the detecting micro-needle. The detecting micro-needle is characterized in that a medical acupuncture needle is used a basis for preparation. A metal nanometer material layer and a high molecular material layer with a strengthened Raman and a fluorescence signal cover the surfaces of the needle body and the needle tip part of the micro-needle. The detecting micro-needle structure comprises a micro-needle with a mercapto and amination surface, a metal nanoparticle layer and a high molecular material layer. The metal nanoparticles with a diameter of 20-1000nm coat the surface of the acupuncture needle by a covalent bond or a static adsorption effect. The high molecular layer covers the protecting metal nanoparticles in the outmost layer. Raman and fluorescence detection of in vitro samples and sampling and minimally invasive sampling and Raman and fluorescence detection in organism can be carried out based on the features of the detecting micro-needle. A novel rapid and super-sensitive detecting method for in vivo and in vitro experiment research, clinical diagnosis and large sample screening is provided by the invention.
Owner:SOUTHEAST UNIV

Highly effective polypeptide for inhibiting angiogenesis, physical chemistry modifying method and application thereof

The invention relates to a high-performance angiogenesis inhibitor and a production method, which belongs to the field of the biological engineering pharmaceutical technology or protein polypeptide drugs. The invention designs a high-performance angiogenesis inhibitor RGD-ED with integrin compatibility, the inhibitor contains angiogenesis inhibition polypeptide isoleucine-valine-arginine-arginine-alanine-aspartate-arginine-alanine-alanine-valine-proline, and one or two ends of the inhibitor are respectively connected with polypeptides containing arginine-glycin-aspartate sequence. The RGD-ED of the invention can be synthesized. By the method of genetic engineering, the invention also expresses one of RGD-Eds in escherichia coli or other eukaryotic cells, and the RGD-ED is obtained by carrying out the separation, dissolution and renaturation of inclusion body protein and separation and purification by ion exchange chromatography. All the polypeptide sequences of the invention are modified by Polyethylene Glycol (PEG), heparin, dextran, polyvinylpyrrolidone (PVP), polyglycol-poly (amino acid) copolymer, palmitic acid, colominic acid and liposome, which includes liposome (REV), drying liposomal (DRV) and multivesicular liposome (Mvl). In vivo and in vitro experiments, the synthetic polypeptide sequence, product of genetic engineering and modified product of the invention can notably increase the effects of inhibiting the growth of endothelial cells, inhibiting angiogenesis and resisting tumor of the present angiogenesis inhibitors, and moreover, the high-performance angiogenesis inhibitor can be used as a drug curing solid tumors and rheumatoid arthritis.
Owner:CHINA PHARM UNIV

Multifunctional multimode tumor-specific targeting phase-change nano-microsphere photoacoustic contrast medium and application thereof

The invention discloses a multifunctional multimode tumor-specific targeting phase-change nano-microsphere photoacoustic contrast medium, structurally comprising, from outside to inside, a ligand that is positioned on the surface of nano-microspheres and specifically binds with a tumor cell membrane surface receptor; the ligand is connected with shell membrane material through linker molecules, and the shell membrane material wraps photo-absorbers and phase-change molecules to the core. A preparation method of the medium includes: linking the ligand to the shell membrane material through the linker molecules by a 'five-step process' to prepare a targeting shell; wrapping the photo-absorbers and phase-change molecules to the core of the nano-microspheres by a special double-emulsification process, while making sure the targeting ligand is positioned on the surface of the nano-microspheres. In-vivo and in-vitro experiments indicate that the photoacoustic contrast medium may specifically bind with tumor cells to experience phase change; there are strong photoacoustic, ultrasonic and X-ray signals, and the medium is applicable to photoacoustic imaging, ultrasonic imaging and computed tomography.
Owner:CHONGQING MEDICAL UNIVERSITY

Gene related to liver cancer and application thereof

The invention discloses a gene related to liver cancer and application thereof. Specifically, the gene is ENSG00000260285. According to the gene disclosed by the invention, up-regulated expression of the ENSG00000260285 in a liver cancer patient is found for the first time through high-throughput sequencing, and differential expression of the gene in the liver cancer patient is further verified by qPCR. Bioinformatic analysis finds that the ENSG00000260285 has higher accuracy when serving as a diagnosing marker of the liver cancer. According to the gene disclosed by the invention, in-vitro experiments find that restraining expression of the ENSG00000260285 can affect physiological characteristics of liver cancer cells, so that the gene can serve as a potential target to be applied to treating liver cancer.
Owner:QINGDAO MEDINTELL BIOMEDICAL CO LTD

Thieno-pyrimidone DPP-IV (dipeptidyl peptidase) inhibitor

The invention belongs to the technical field of medicines, and in particular relates to a compound taking thieno-pyrimidone as mother nuclide or a salt thereof, a preparation method and a combination of the compound and application of the compound used as a DPP-IV (dipeptidyl peptidase) inhibitor in preventing or treating diseases benefiting from the DPP-IV inhibition. The compound provided by the invention has the advantages that the preparation process is simple, the raw material is easily available, the compound is suitable for large-scale production, and in-vitro experiment verifies that the compound has good selective inhibition action on the DPP-IV, and hardly has any influence on the activities of DPP-VIII and DPP-IX while effectively inhibiting the activity of the DDP-IV, thereby predicting that the medicine prepared from the compound has very low toxicity and an outstanding advantage.
Owner:GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI +1

MYOZ1 gene and application of expression product of MYOZ1 gene in diagnosing and treating parkinsonism

The invention discloses application of MYOZ1 in diagnosing and treating parkinsonism, belonging to the technical field of new application of genes. The experiment proves that the MYOZ1 gene expression in the blood of a parkinsonism patient is enhanced as compared with a normal person, which indicates that the MYOZ1 expression level in the blood can be detected to diagnose whether a subject suffers from parkinsonism. The in-vitro MTT experiment detect that the MYOZ1 gene expression is not beneficial to growth of human neuroblastoma cells. Therefore, the MYOZ1 has favorable development and application prospects in preparing products for diagnosing and treating parkinsonism.
Owner:QINGDAO MEDINTELL BIOMEDICAL CO LTD

D-configuration polypeptide with brain tumor targeting and tumor tissue penetrating capabilities and gene delivery system thereof

The invention belongs to the field of pharmacy and relates to a D-configuration polypeptide and a gene delivery system of the D-configuration polypeptide and particularly relates to the D-configuration polypeptide which has high combining activity with neuropilin NRP-1 and has the brain tumor targeting and tumor tissue penetrating capabilities. The D-configuration polypeptide provided by the invention can mediate a nano delivery system to deliver drugs to tumors in a targeted manner for realizing targeted treatment of brain in-situ glioma. In vivo and in vitro experiments show that the genetic vector modified by the D-configuration polypeptide can remarkably improve the gene transfection efficiency. The genetic vector entrapping the therapeutic gene pORF-hTRAIL can remarkably prolong the lifetime of a nude mouse of brain glioma in-situ mode.
Owner:FUDAN UNIV

Ursolic acid-aspirin conjugate and application thereof in preparing drugs for preventing tumor metastasis

The invention relates to a ursolic acid-aspirin conjugate shown in a formula (I) and application thereof in preparing drugs for preventing tumor metastasis. In vivo experiments verify that the ursolic acid-aspirin conjugate provided by the invention has a remarkable inhibitory effect on adhesion, migration, invasion and the like of tumor cells. in vivo animal experiments verify that the ursolic acid-aspirin conjugate can be used for reducing experimental pulmonary metastasis of 4T1 breast cancer of a rat and showing a relatively good tumor metastasis resisting effect. The ursolic acid-aspirin conjugate provided by the invention can be applied to preventive drugs for tumor metastasis, thereby providing novel selection for developing new drugs for tumor metastasis and preventing postoperative retransfer of malignant tumors. The formula (I) is shown in the description.
Owner:FUZHOU UNIV

Application of bakuchiol compound

InactiveCN101088498AAchieve therapeuticAchievement or effect of neurological diseaseNervous disorderHydroxy compound active ingredientsDiseaseCytotoxicity
The present invention discloses the application of bakuchiol compound in preparing medicine for treating psychogenic diseases and neurogenic diseases. Extracorporeal experiment and animal experiment show that the bakuchiol compound can suppressing dopamine transport protein, noradrenalin transport protein and 5-hydroxy tryptamine transport protein selectively, and no influence on gamma-aminobutyric acid transport protein and L-glytamic acid transport protein, no cytotoxicity, and antidepressant effect higher than available antidepressant medicine amfebutamoe hydrochloride. Therefore, the bakuchiol compound has excellent marketability in preparing medicine for treating psychogenic diseases and neurogenic diseases.
Owner:上海国联干细胞技术有限公司

Preparation method and kit of bispecific chimeric antigen receptor gene modified natural killer cells

The invention provides a preparation method of bispecific chimeric antigen receptor gene modified natural killer cells, comprising the features: constructing a bispecific chimeric antigen receptor gene containing specific-binding signaling lymphocyte activation molecule family member 7 and fibronectin mutants, recombining the bispecific chimeric antigen receptor gene to a viral vector, transfecting with human natural killer cells, and highly expressing the bispecific chimeric antigen receptor gene, thus specifically binding tumor cells that express the signaling lymphocyte activation molecule family member 7 and fibronectin mutants, inhibiting expression of natural killer cell inhibitory receptors, and preventing immune escape of tumor cells; meanwhile, activating a first signal and a co-stimulatory signal to trigger toxic activity of the tumor cells, and great anti-tumor killing toxicity is shown in in-vivo and in-vitro experiments; the invention also provides a kit for the preparation of autologous natural killer cells through the above method, and with the kit, it is possible to highly express the bispecific chimeric antigen receptor gene and trigger great anti-tumor effect.
Owner:ZICHENG RUISHENGHUI BEIJING BIOTECH DEV CO LTD

Method for preparing polypeptide by beer sediment

The invention discloses a method for preparing polypeptide by beer sediment. The method comprises the following steps: drying, pulverizing and sieving wet beer sediment to obtain beer sediment; adding extractant to the beer sediment and stirring the mixture at room temperature, filtering, deslagging and centrifuging the mixture to obtain protein extracting solution; adjusting pH value to 4.0-5.0 for precipitation; removing supernatant, carrying out vacuum freeze drying to obtain crude polypeptide; adding disodium hydrogen phosphate-citric acid buffer solution to the beer sediment crude protein, adjusting pH value of the mixture to 6.5-8.5; adding Alcalase alkaline protein enzyme, heating to 45-65 DEG C, carrying out hydrolysis for 1-5h while the mixture is stirred; afterwards killing enzyme in boiling water and centrifuging the mixture; taking centrifuged supernatant for gel column analysis and respectively collecting peaks and then carrying out concentration and freeze drying to obtain active polypeptide. In the method of the invention no harmful substance is introduced, the product is made of natural materials and enjoys wide material source, so that the natural active substances prove to have obvious blood-sugar-level-regulate activity according to in vitro experiments.
Owner:SOUTH CHINA UNIV OF TECH

HUVEC (human umbilical vein endothelial cell) separation, culture and subculture method

The invention relates to an HUVEC (human umbilical vein endothelial cell) separation, culture and subculture method belonging to the technical field of biology. The method comprises the following steps: (1) separation of HUVEC: taking a fresh umbilical cord, cleaning with a sterile PBS (phosphate buffer solution) containing penicillin-streptomycin, adding collagenase to perform water bath digestion at 37 DEG C, centrifuging the digestion solution, then adding an M199 culture medium, transferring into a gelatin-coated culture bottle, and culturing in a CO2 incubator at 37 DEG C; (2) culture of HUVEC: after the HUVEC is cultured at 37 DEG C for 24 hours, pouring out the culture medium, cleaning with the PBS, adding a fresh M199 culture medium, and afterwards, changing the culture medium once every two days, wherein the HUVEC can be subcultured generally after being cultured for 5-7 days; and (3) subculture of HUVEC: pouring out the culture medium, cleaning with the PBS, adding the digestion solution to digest the cell, adding a DMEM (dulbecco's modified eagle medium) containing serum to terminate the reaction once the cell is rounded, centrifuging the digested cell, and adding a fresh culture medium, wherein the HUVEC subcultured for 2-3 generations is used for experiments. The separated HUVEC is economical and practical, is simple and easy to use, and is beneficial to obtaining required in-vitro experimental model cells.
Owner:JIANGSU ACADEMY OF AGRICULTURAL SCIENCES

Use of 8-0-4'type lignan in preparing anticomplement medicament

The invention belongs to the field of Chinese traditional medicines and relates to a new use of 8-0-4' lignan in preparing an anti-complement medicine. The compound 8-0-4' lignan is extracted from a Chinese medicinal herb eucommia bark, and in vitro experiments prove that the compound 8-0-4' lignan can inhibit cell hemolysis caused by the activations of classical and alternative pathways of a complement system, and has obvious inhibitory action on the activation of the classical and alternative pathways of the complement system; and the results of pharmacological tests prove that the compound 8-0-4' lignan has obvious anti-complement effect and low effective concentration. The compound 8-0-4' lignan of the invention can be further taken as an active ingredient for preparing a novel anti-complement medicine.
Owner:FUDAN UNIV

Method for evaluating activity of bio-feed

The invention relates to a method for evaluating activity of a bio-feed. Concretely speaking, the invention relates to a method for evaluating activity of the bio-feed by taking intestinal flora as a target object, an aseptic animal is used for detecting the positive or negative fluctuation of the animal intestinal flora for through 16S rDNA sequencing, and the activity of the bio-feed is evaluated. The method can be used for evaluating activity of various bi-feeds, the effect of a detection substance by the intestinal flora can be detected through in-vivo and in-vitro experiment, and the superiority-inferiority of the sample can be reflected through flora fluctuation.
Owner:深圳市前海金卓生物技术有限公司

Preparation method, application and medicine composition and preparation of specific egg yolk immunoglobulin (IgY) and acinetobacter baumannii, as well as preparation and kit

The invention provides a preparation method, application and medicine composition and preparation of specific egg yolk immunoglobulin (IgY) and acinetobacter baumannii, as well as a preparation and a kit. The preparation method is characterized by comprising the following steps of: preparing antigen liquor, immunizing hens, and separating and purifying the IgY. In-vivo and in-vitro experiments prove that the prepared specificity IgY has specific binding activity to the acinetobacter baumannii, can be used for effectively inhibiting the growth of the acinetobacter baumannii and alleviating a toxic effect generated by the acinetobacter baumannii, can be applied to prevention, treatment and diagnostic analysis on infectious diseases and complications of the acinetobacter baumannii, and has wide application prospect.
Owner:DALIAN MEDICAL UNIVERSITY

Preparation method and application of multifunctional membrane-controlled targeting nano-carrier integrating tracing and targeted drug delivery effects

The invention belongs to the technical fields of preparation and applications of nano-carriers, and in particular discloses a preparation method and an application of a multifunctional membrane-controlled targeting nano-carrier integrating tracing and targeted drug delivery effects. With nano mesoporous silica (MSN) as a drug 'warehouse', a positively charged high molecular material and a negatively charged high molecular material as preparation materials of a gating membrane, and adriamycin (DOX), cis-platinum, imatinib, taxol and the like as model anti-cancer drugs, research contents mainlyinclude optimization and improvement of natural materials, construction and process optimization of the gating membrane, structural characterization of a nano complex, drug release kinetic characteristics of drug molecules under the control of the gating membrane, and the like. Meanwhile, in the combination with the tracing imaging function of a fluorescent quantum dot, drug delivery behaviors andanti-tumor effectiveness of the membrane-controlled nano drug delivery system undergo preliminary evaluation through in-vitro experiments. Based upon research results, references are provided for thedesign and preparation of the novel membrane-controlled nano drug delivery system.
Owner:SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES

Bionic bleeding stopping biological glue

The invention provides bionic bleeding stopping biological glue with an amino acid sequence of SEQ ID NO:1. The invention also provides a bleeding stopping material which contains a protein with an amino acid sequence of SEQ ID NO:1 and sodium alginate modified by Dopa. The invention provides a product with bleeding stopping performance, and the product is prepared from polypeptide with an amino acid sequence SEQ ID NO:1 and a sodium alginate derivative; and application results show that the protein with the amino acid sequence of SEQ ID NO:1 can be used for improving ultramicrostructures, and in vitro experiments prove that the composite has good bleeding stopping effect.
Owner:OCEAN UNIV OF CHINA

Carrot seed antioxidant tripeptide as well as preparation method and application thereof

The invention discloses a carrot seed antioxidant tripeptide as well as a preparation method and an application thereof. The sequence of the carrot seed antioxidant tripeptide is Tyr-Ser-Leu (YSL). The in-vitro experiment shows that DPPH and ABTS free radicals can be effectively removed by the tripeptide, and meanwhile the tripeptide is relatively good in stability. The carrot seed antioxidant tripeptide disclosed by the invention has the characteristics of simple structure, high antioxidant activity, and the like, can be used as assistant and substitute of an artificially synthesized antioxidant, and has important values for development and application of novel antioxidant healthcare products.
Owner:FUZHOU UNIV

Method for separating and extracting sweet tea tannins

The invention relates to the separation and extraction methods of a sweet tea polyphenols. The invention uses integration of ultrafiltration with resin adsorption separation technique. Only ethanol is used as organic solvent during producing process and the separation technique of sweet tea polyphenols is optimized; the simple operation helps realize industrialized production; besides, the production process accords with environment protection requirement and the products accord with food and drug raw material requirements. The invention uses Guangxi sweet tea as raw materials to produce sweet tea polyphenols containing over 50% and 90%. Hyaluronidase inhibition in vitro experiment, in vivo experiments of mice passive dermato-allergic reaction and the delayed cutaneous hypersensitivity caused by dinitro-chlorobenzene confirm the invention has significant anti-anaphylaxis activity.
Owner:GUANGXI UNIV

Lactobacillus for producing lactic acid and H2O2 and application of lactobacillus

ActiveCN111088178ALactic acid producing (strain B3 strongStrong B7Antibacterial agentsAntimycoticsBiotechnologyMicrobiology
The invention discloses lactobacillus for producing lactic acid and H2O2 and an application of the lactobacillus. The lactobacillus is lactobacillus gasseri or lactobacillus crispatus, wherein the preservation number of the lactobacillus gasseri is CGMCC No. 15815 or CGMCC No. 15816; the preservation number of the lactobacillus crispatus is CGMCC No. 15813 or CGMCC No. 15814. The lactobacillus gasseri and lactobacillus crispatus provided by the invention have extremely strong lactic acid and H2O2 production ability, have good ability to adhere to vaginal epithelial cells, and can effectively inhibit reproduction of pathogenic bacteria like Gardner bacteria and Candida albicans in in-vivo and in-vitro experiments.
Owner:SHANGHAI SINE PHARMA LAB

Preparation method of exosome and stem cell proliferation reagent containing exosome

The invention discloses a preparation method of exosome and a stem cell proliferation reagent containing the exosome. The preparation method of the exosome comprises the steps that 1, a culture mediumwithout exosome serum is added bone marrow mesenchymal stem cells to dilute the bone marrow mesenchymal stem cells into a cell suspension, the cell suspension is inoculated into a cell culture bottleto be cultured, supernate obtained after culture is collected, and the exosome is extracted; 2, cell fragments, dead cells and impurities in the supernate are removed; the supernate is removed, thena phosphate buffer salt solution (PBS) is added to dissolve and collect exosome precipitate, the exosome precipitate is filtered through a sterile filter membrane, and the obtained exosome precipitateis packaged in a sterile centrifugal tube and stored for later use. According to the method, in-vitro experiments prove that the proliferation activity and related functions of the mesenchymal stem cells can be remarkably promoted by co-culturing the exosome secreted by the early-generation bone marrow mesenchymal stem cells and human umbilical cord mesenchymal stem cells, and the method is an effective strategy for potentially improving the function of cells in a large-scale cell culture process.
Owner:广东芙金干细胞再生医学有限公司

Polypeptin and preparation and application thereof

The invention provides novel polypeptin having potential value of biological control and medical applications, and a preparation method and application thereof. The structure of the polypeptin is shown as a formula (I). The invention has the advantages of providing the polypeptin which has the toxicity lower than that of polymyxin B and has the potential value of biological control and medical applications, and the preparation method and the application thereof. In vitro experiments show that the compound has the obvious effect of inhibiting all the tested gram-positive bacterium, gram-negative bacterium and fungi. Disk-culturing experiments show that the compound has certain effect of preventing and treating various fungal plant diseases and particularly has obvious effects of preventing and treating rice sheath blight.
Owner:ZHEJIANG UNIV +1

Yarn for cell culture scaffold, and fabric including the same for cell culture scaffold

Provided is yarn for a cell culture scaffold. The yarn includes ply-twisted fiber strands, and to prevent density-dependent inhibition of cultured cells and increase a cell-contacting specific surface area, at least a part of the plurality of twisted fiber strands are untwisted such that an open space is formed between the fibers. A cell proliferation rate and cell viability may be increased by creating microenvironments suitable for migration, proliferation and differentiation of the cultured cells using the yarn. A large quantity of cells may be simultaneously cultured by creating a cell proliferation space as large as possible in a scaffold space having a limited cell proliferation space, and cell proliferation may be steadily maintained by preventing the inhibition of cell proliferation due to intercellular contact. The cells cultured may be cultured to have a shape / structure suitable for application to an in vitro experiment model or implantation into an animal body.
Owner:AMOLIFESCI CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products